According to the watchdog, Ozempic in South Africa is registered under two presentations of pre-filled injectable pens, namely 0.25mg and 0.5 mg/dose pen and 1 mg/dose pen.

Lizzo’s Halloween costume is more than a look this year—it’s a response to Ozempic allegations amid her weight loss and to a South Park episode that jabbed at her body-positive message back ...

In the main, people have complimented my weight loss, but more recently some have openly suggested that it was because of ...

One in eight adults in the US have tried GLP-1 medications like Ozempic and Wegovy, but despite their massive popularity, many people taking the drug do so in secret. The Post spoke to three, plus ...

Skinny jab? Try skinny juice. A natural, plant-based drink enjoyed for centuries in South America may help you reach your weight loss goals the same way GLP-1 medications do. And it puts Ozempic ...

Skinny jab? Try skinny juice. A natural, plant-based drink enjoyed for centuries in South America may help you reach your weight loss goals the same way GLP-1 medications do. And it puts Ozempic ...

The Ozempic that CNBC purchased is considered an illegally diverted drug. A separate but related growing problem is the rise of counterfeit drugs — fake products purporting to be the real thing.

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks ...

A recent study linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss. Here's what you should know.

You may have heard about Ozempic, a medicine for type 2 diabetes approved by the FDA in 2017. This medicine is for use with diet and exercise to improve control of blood glucose levels in people ...

Should Everyone Be Taking Ozempic? Doctors Say More People Could Benefit. Anti-obesity drugs are showing promise for ever-expanding list of diseases. By . Peter Loftus. Share. Resize. Listen ...